These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7994792)

  • 1. Prophylactic intravesical chemotherapy with adriamycin plus verapamil for primary superficial bladder cancer: preliminary results. The Kyushu University Urological Oncology Group.
    Naito S; Ueda T; Kotoh S; Iguchi A; Sagiyama K; Hiratsuka Y; Osada Y; Ariyoshi A; Omoto T; Kumazawa J
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S76-80. PubMed ID: 7994792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic intravesical instillation chemotherapy against recurrence after a transurethral resection of superficial bladder cancer: a randomized controlled trial of doxorubicin plus verapamil versus doxorubicin alone. The Kyushu University Urological Oncology Group.
    Naito S; Kotoh S; Omoto T; Osada Y; Sagiyama K; Iguchi A; Ariyoshi A; Hiratsuka Y; Kumazawa J
    Cancer Chemother Pharmacol; 1998; 42(5):367-72. PubMed ID: 9771950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy with early intravesical instillation of adriamycin and long-term oral administration of 5-fluorouracil in superficial bladder cancer. The Kyushu University Urological Oncology Group.
    Ueda T; Naito S; Iguchi A; Sagiyama K; Osada Y; Ariyoshi A; Omoto T; Kumazawa J
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S31-6. PubMed ID: 1394813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical instillation chemotherapy of adriamycin with or without verapamil for the treatment of superficial bladder cancer: the final results of a collaborative randomized trial.
    Tsushima T; Ohmori H; Ohi Y; Shirahama T; Kawahara M; Matsumura Y; Ohashi Y
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S69-75. PubMed ID: 7994791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of the preoperative intravesical instillation of doxorubicin and the oral administration of 5-fluorouracil in preventing recurrence after a transurethral resection of superficial bladder cancer. Kyushu University Urological Oncology Group.
    Naito S; Iguchi A; Sagiyama K; Ariyoshi A; Osada Y; Omoto T; Kuriya N; Kumazawa J
    Int J Urol; 1997 Jul; 4(4):352-7. PubMed ID: 9256323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical therapy with adriamycin plus verapamil in patients with superficial bladder cancer: a pilot study.
    Naito S; Kimiya K; Ueda T; Kumazawa J; Omoto T; Osada Y; Iguchi A; Ariyoshi A; Sagiyama K
    Urol Int; 1992; 48(3):270-3. PubMed ID: 1589915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic chemotherapy for primary and recurrent superficial bladder cancer: preliminary results. The Hokkaido University Bladder Cancer Collaborating Group.
    Togashi M; Shinohara N; Toyota K; Koyanagi T; Maru A; Fujieda J; Kawakura K; Nishida T; Ohashi N
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S21-5. PubMed ID: 1394811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the prophylactic usefulness of epirubicin and doxorubicin in the treatment of superficial bladder cancer by intravesical instillation: a multicenter randomized trial. Kobe University Urological Oncology Group.
    Eto H; Oka Y; Ueno K; Nakamura I; Yoshimura K; Arakawa S; Kamidono S; Obe S; Ogawa T; Hamami G
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S46-51. PubMed ID: 7994786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic chemotherapy with anthracyclines (adriamycin, epirubicin, and pirarubicin) for primary superficial bladder cancer. The Hokkaido University Bladder Cancer Collaborative Group.
    Shinohara N; Nonomura K; Tanaka M; Nagamori S; Takakura F; Seki T; Koyanagi T; Togashi M; Maru A
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S41-5. PubMed ID: 7994785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic chemotherapy with intravesical instillation of adriamycin and oral administration of 5-fluorouracil after surgery for superficial bladder cancer. The Japanese Urological Cancer Research Group for Adriamycin.
    Obata K; Ohashi Y; Akaza H; Isaka S; Kagawa S; Koiso K; Kotake T; Machida T; Matsumura Y; Niijima T
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S88-92. PubMed ID: 7994795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic intravesical instillation therapy with adriamycin and mitomycin C in patients with superficial bladder cancer.
    Tsushima T; Matsumura Y; Ozaki Y; Yoshimoto J; Ohmori H
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S72-6. PubMed ID: 3117400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of prophylactic intravesical chemotherapy with 4'-epirubicin in recurrent superficial bladder cancer: comparison of 4'-epirubicin and adriamycin.
    Shuin T; Kubota Y; Noguchi S; Hosaka M; Miura T; Kondo I; Fukushima S; Ishizuka E; Furuhata A; Moriyama M
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S52-6. PubMed ID: 7994787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 4th study of prophylactic intravesical chemotherapy with adriamycin in the treatment of superficial bladder cancer: the experience of the Japanese Urological Cancer Research Group for Adriamycin.
    Matsumura Y; Akaza H; Isaka S; Kagawa S; Koiso K; Kotake T; Machida T; Niijima T; Obata K; Ohashi Y
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S10-4. PubMed ID: 1394809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prophylactic intravesical instillation therapy in patients with superficial bladder cancer--results of a randomized prospective study].
    Tsushima T; Nasu Y; Abeki N; Noda M; Saika T; Ohmori H; Kobashi K; Ozaki Y; Matsumura Y; Tanahashi T
    Nihon Hinyokika Gakkai Zasshi; 1992 Aug; 83(8):1314-21. PubMed ID: 1405170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study.
    Martinez-Pineiro JA; Jimenez León J; Martinez-Pineiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
    Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder.
    Koga H; Kuroiwa K; Yamaguchi A; Osada Y; Tsuneyoshi M; Naito S
    J Urol; 2004 Jan; 171(1):153-7. PubMed ID: 14665865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical instillation of adriamycin in the presence or absence of verapamil for the treatment of superficial bladder cancer: preliminary report of a collaborative study.
    Ohi Y; Ohmori H; Shirahama T; Kawahara M; Matsumura Y; Tsushima T; Ohashi Y
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S50-4. PubMed ID: 1394818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Postoperative prophylactic intravesical instillation of tetrahydropyranyl-adriamycin (THP) for superficial bladder cancer].
    Kanayama H; Yokota K; Kurokawa Y; Kagawa S; Yokozeki H; Inai T; Ogawa I; Akazawa S; Hashimoto H; Mizuta K
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):651-5. PubMed ID: 10234296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravesical instillation of doxorubicin or epirubicin for chemoprophylaxis of superficial bladder cancer--the fifth study of the Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin].
    Hinotsu S; Akaza H; Isaka S; Kagawa S; Koiso K; Kotake T; Machida T; Matsumura Y; Niijima T; Obata K; Ohashi Y; Ohe H; Shimazaki J; Tashiro K;
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):73-80. PubMed ID: 11816482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of intravesical chemoprophylaxis of superficial bladder cancer: experience of the Japanese Urological Cancer Research Group for Adriamycin.
    Akaza H; Koiso K; Kotake T; Matsumura Y; Isaka S; Machida T; Obata K; Ohashi Y; Ohe H; Ohi Y
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S15-20. PubMed ID: 1394810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.